Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

BACKGROUND: The efficacy and safety of capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer (mCRC) considered unsuitable for receiving first-line chemotherapy with an irinotecan or oxaliplatin-based combination were assessed in a phase II, open, multicentre, uncontrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Feliu, J, Safont, M J, Salud, A, Losa, F, García-Girón, C, Bosch, C, Escudero, P, López, R, Madroñal, C, Bolaños, M, Gil, M, Llombart, A, Castro-Carpeño, J, González-Barón, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869164/
https://www.ncbi.nlm.nih.gov/pubmed/20424611
http://dx.doi.org/10.1038/sj.bjc.6605663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869164/
https://www.ncbi.nlm.nih.gov/pubmed/20424611
http://dx.doi.org/10.1038/sj.bjc.6605663

Ejemplares similares